Journal Article

Inhibition of 12-<i>O</i>-tetradecanoylphorbol-13-acetate-induced NF-κB activation by tea polyphenols, (–)-epigallocatechin gallate and theaflavins

Masaaki Nomura, Wei-ya Ma, Nanyue Chen, Ann M. Bode and Zigang Dong

in Carcinogenesis

Volume 21, issue 10, pages 1885-1890
Published in print October 2000 | ISSN: 0143-3334
Published online October 2000 | e-ISSN: 1460-2180 | DOI:
Inhibition of 12-O-tetradecanoylphorbol-13-acetate-induced NF-κB activation by tea polyphenols, (–)-epigallocatechin gallate and theaflavins

More Like This

Show all results sharing this subject:

  • Clinical Cytogenetics and Molecular Genetics


Show Summary Details


(–)-Epigallocatechin gallate (EGCG) and theaflavins are believed to be the key active components in tea for the chemoprevention of cancer. However, the molecular mechanisms by which EGCG and theaflavins block carcinogenesis are not clear. In the JB6 mouse epidermal cell line a tumor promoter 12-O-tetradecanoylphorbol-13-acetate (TPA), which causes cell transformation at high frequency, markedly induced NF-κB activation. We found that EGCG and theaflavins inhibited TPA-induced NF-κB activity in a concentration-dependent manner. These polyphenols blocked TPA-induced phosphorylation of IκBα at Ser32 in the same concentration range. Moreover, the NF-κB sequence-specific DNA-binding activity induced by TPA was also inhibited by these polyphenols. These results suggest that inhibition of NF-κB activation is also important in accounting for the anti-tumor promotion effects of EGCG and theaflavins.

Keywords: AP-1, activator protein-1; EGF, epidermal growth factor; EGCG, (–)-epigallocatechin gallate; FBS, fetal bovine serum; MEM, minimum essential medium; NF-κB, nuclear factor κB, P+, tumor promoter sensitive; P–, tumor promoter resistant; PKC, protein kinase C; TPA, 12-O-tetradecanoylphorbol-13-acetate.

Journal Article.  4490 words.  Illustrated.

Subjects: Clinical Cytogenetics and Molecular Genetics

Full text: subscription required

How to subscribe Recommend to my Librarian

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.